CIK 1839948
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 95.13% | 48 |
| Unclassified | 4.87% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ABVX | Abivax S.A. | Health Care | 20.65% |
| 2 | CGON | CG Oncology, Inc. | Health Care | 7.11% |
| 3 | TNGX | Tango Therapeutics, Inc. | Health Care | 6.30% |
| 4 | COGT | Cogent Biosciences, Inc. | Health Care | 5.45% |
| 5 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 4.87% | |
| 6 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Health Care | 4.03% |
| 7 | TYRA | Tyra Biosciences, Inc. | Health Care | 3.56% |
| 8 | IMVT | Immunovant, Inc. | Health Care | 3.17% |
| 9 | BCRX | BIOCRYST PHARMACEUTICALS INC | Health Care | 3.00% |
| 10 | MIRM | Mirum Pharmaceuticals, Inc. | Health Care | 2.81% |
48/49 names classified · sector 95.1% of weight · industry 95.1% · mkt cap 73.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 3% of book weight classified — the grid is NOT representative of the whole book.
Classified: 3.0% of book weight (1/49 names) · unclassified 97.0%: ABVX, CGON, TNGX, COGT, , DNTH, TYRA, IMVT, MIRM, VOR +38 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 6,481,085 | $722M | 20.6% | TRIM −9% |
| 2 | CGONCG ONCOLOGY INC | 3,670,206 | $248M | 7.1% | HOLD |
| 3 | TNGXTANGO THERAPEUTICS INC | 10,531,071 | $220M | 6.3% | TRIM −17% |
| 4 | COGTCOGENT BIOSCIENCES INC | 4,946,894 | $190M | 5.4% | TRIM −16% |
| 5 | CENTESSA PHARMACEUTICALS PLC | 4,286,480 | $170M | 4.9% | HOLD |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 1,676,624 | $141M | 4.0% | HOLD |
| 7 | TYRATYRA BIOSCIENCES INC | 3,248,980 | $124M | 3.6% | ADD 12% |
| 8 | IMVTIMMUNOVANT INC | 4,457,988 | $111M | 3.2% | ADD 168% |
| 9 | BCRXBIOCRYST PHARMACEUTICALS INC | 11,020,968 | $105M | 3.0% | NEW |
| 10 | MIRMMIRUM PHARMACEUTICALS INC | 1,062,049 | $98M | 2.8% | ADD 1612% |
| 11 | VORVOR BIOPHARMA INC | 5,673,078 | $96M | 2.8% | NEW |
| 12 | SYRESPYRE THERAPEUTICS INC | 1,900,582 | $96M | 2.7% | HOLD |
| 13 | AMLXAMYLYX PHARMACEUTICALS INC | 6,243,812 | $87M | 2.5% | HOLD |
| 14 | IRONDISC MEDICINE INC | 1,341,862 | $86M | 2.5% | NEW |
| 15 | DYNDYNE THERAPEUTICS INC | 4,615,144 | $84M | 2.4% | HOLD |
| 16 | GLUEMONTE ROSA THERAPEUTICS INC | 4,622,151 | $76M | 2.2% | HOLD |
| 17 | SVRASAVARA INC | 12,362,205 | $67M | 1.9% | HOLD |
| 18 | RVMDREVOLUTION MEDICINES INC | 576,473 | $56M | 1.6% | ADD 32% |
| 19 | KODKODIAK SCIENCES INC | 1,445,538 | $55M | 1.6% | HOLD |
| 20 | LBRXLB PHARMACEUTICALS INC | 1,839,489 | $45M | 1.3% | ADD 5% |
| 21 | SRZNSURROZEN INC | 1,473,101 | $43M | 1.2% | NEW |
| 22 | ADCTADC THERAPEUTICS SA | 11,390,175 | $43M | 1.2% | HOLD |
| 23 | RLAYRELAY THERAPEUTICS INC | 4,273,356 | $43M | 1.2% | ADD 33% |
| 24 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $40M | 1.2% | HOLD |
| 25 | BHVNBIOHAVEN LTD | 4,631,317 | $39M | 1.1% | HOLD |
| 26 | IPSCCENTURY THERAPEUTICS INC | 17,754,430 | $39M | 1.1% | NEW |
| 27 | TECXTECTONIC THERAPEUTIC INC | 1,204,891 | $37M | 1.1% | NEW |
| 28 | CATXPERSPECTIVE THERAPEUTICS INC | 7,915,567 | $33M | 0.9% | NEW |
| 29 | XNCRXENCOR INC | 2,452,138 | $30M | 0.8% | HOLD |
| 30 | TRDAENTRADA THERAPEUTICS INC | 2,287,500 | $29M | 0.8% | ADD 10% |
| 31 | ALXOALX ONCOLOGY HLDGS INC | 13,011,849 | $26M | 0.7% | NEW |
| 32 | ARVNARVINAS INC | 2,387,461 | $25M | 0.7% | TRIM −10% |
| 33 | JANXJANUX THERAPEUTICS INC | 1,789,617 | $25M | 0.7% | HOLD |
| 34 | AGMBAGOMAB THERAPEUTICS NV | 2,053,233 | $22M | 0.6% | NEW |
| 35 | ALECALECTOR INC | 10,000,000 | $22M | 0.6% | HOLD |
| 36 | MBXMBX BIOSCIENCES INC | 650,000 | $19M | 0.6% | HOLD |
| 37 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $16M | 0.5% | HOLD |
| 38 | LQDALIQUIDIA CORPORATION | 403,048 | $15M | 0.4% | TRIM −76% |
| 39 | OCULOCULAR THERAPEUTIX INC | 1,647,752 | $14M | 0.4% | TRIM −71% |
| 40 | AVTXAVALO THERAPEUTICS INC | 738,383 | $11M | 0.3% | ADD 53% |
| 41 | URGNUROGEN PHARMA LTD | 405,365 | $7M | 0.2% | TRIM −43% |
| 42 | MNPRMONOPAR THERAPEUTICS INC | 132,103 | $7M | 0.2% | TRIM −7% |
| 43 | CNTXCONTEXT THERAPEUTICS INC | 2,682,696 | $7M | 0.2% | NEW |
| 44 | GPCRSTRUCTURE THERAPEUTICS INC | 140,411 | $7M | 0.2% | TRIM −85% |
| 45 | CGEMCULLINAN THERAPEUTICS INC | 406,786 | $6M | 0.2% | NEW |
| 46 | KRROKORRO BIO INC | 416,301 | $5M | 0.1% | HOLD |
| 47 | LONALEONABIO INC | 464,398 | $5M | 0.1% | HOLD |
| 48 | UPBUPSTREAM BIO INC | 181,063 | $2M | 0.0% | TRIM −76% |
| 49 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $2M | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ABVXABIVAX SA | 6.1M | 6.1M | 6.1M | 7.1M | 7.1M | 6.5M | $722M |
| CGONCG ONCOLOGY INC | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | $248M |
| TNGXTANGO THERAPEUTICS INC | 10.7M | 10.7M | 10.7M | 8.5M | 12.8M | 10.5M | $220M |
| COGTCOGENT BIOSCIENCES INC | 7.0M | 7.0M | 7.0M | 6.8M | 5.9M | 4.9M | $190M |
| CENTESSA PHARMACEUTICALS PLC | 2.9M | 2.9M | 2.9M | 3.1M | 4.3M | 4.3M | $170M |
| DNTHDIANTHUS THERAPEUTICS INC | 1.5M | 1.5M | 1.5M | 1.7M | 1.7M | 1.7M | $141M |
| TYRATYRA BIOSCIENCES INC | 2.0M | 2.9M | 2.9M | 2.9M | 2.9M | 3.2M | $124M |
| IMVTIMMUNOVANT INC | — | — | — | — | 1.7M | 4.5M | $111M |
| BCRXBIOCRYST PHARMACEUTICALS INC | — | — | — | — | — | 11.0M | $105M |
| MIRMMIRUM PHARMACEUTICALS INC | — | — | — | — | 62K | 1.1M | $98M |
| VORVOR BIOPHARMA INC | — | — | — | — | — | 5.7M | $96M |
| SYRESPYRE THERAPEUTICS INC | — | — | — | 1.1M | 1.9M | 1.9M | $96M |
| AMLXAMYLYX PHARMACEUTICALS INC | 4.6M | 5.9M | 5.9M | 6.2M | 6.2M | 6.2M | $87M |
| IRONDISC MEDICINE INC | 487K | 465K | 465K | 465K | — | 1.3M | $86M |
| DYNDYNE THERAPEUTICS INC | 2.7M | 2.7M | 3.8M | 4.6M | 4.6M | 4.6M | $84M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
